Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Weber S, van der Leest P, Donker HC, Schlange T, Timens W, Tamminga M, Hasenleithner SO, Graf R, Moser T, Spiegl B, Yaspo ML, Terstappen LWMM, Sidorenkov G, Hiltermann TJN, Speicher MR, Schuuring E, Heitzer E, Groen HJM. Weber S, et al. Among authors: hasenleithner so. JCO Precis Oncol. 2021 Nov;5:1540-1553. doi: 10.1200/PO.21.00182. JCO Precis Oncol. 2021. PMID: 34994642
On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer.
Moser T, Waldispuehl-Geigl J, Belic J, Weber S, Zhou Q, Hasenleithner SO, Graf R, Terzic JA, Posch F, Sill H, Lax S, Kashofer K, Hoefler G, Schoellnast H, Heitzer E, Geigl JB, Bauernhofer T, Speicher MR. Moser T, et al. Among authors: hasenleithner so. NPJ Precis Oncol. 2020 Nov 13;4(1):30. doi: 10.1038/s41698-020-00134-3. NPJ Precis Oncol. 2020. PMID: 33299124 Free PMC article.
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.
Riedl JM, Hasenleithner SO, Pregartner G, Scheipner L, Posch F, Groller K, Kashofer K, Jahn SW, Bauernhofer T, Pichler M, Stöger H, Berghold A, Hoefler G, Speicher MR, Heitzer E, Gerger A. Riedl JM, et al. Among authors: hasenleithner so. Ther Adv Med Oncol. 2021 Feb 27;13:1758835920987658. doi: 10.1177/1758835920987658. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33717225 Free PMC article.
LBFextract: Unveiling transcription factor dynamics from liquid biopsy data.
Lazzeri I, Spiegl BG, Hasenleithner SO, Speicher MR, Kircher M. Lazzeri I, et al. Among authors: hasenleithner so. Comput Struct Biotechnol J. 2024 Aug 11;23:3163-3174. doi: 10.1016/j.csbj.2024.08.007. eCollection 2024 Dec. Comput Struct Biotechnol J. 2024. PMID: 39660220 Free PMC article.
How to detect cancer early using cell-free DNA.
Hasenleithner SO, Speicher MR. Hasenleithner SO, et al. Cancer Cell. 2022 Dec 12;40(12):1464-1466. doi: 10.1016/j.ccell.2022.11.009. Cancer Cell. 2022. PMID: 36513047 Free article.